Boehringer Ingelheim yesterday announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center in Zhangjiang, Shanghai.
ARTES Biotechnology has announced a collaboration with global pharmaceutical company, Boehringer Ingelheim Animal Health. ARTES Biotechnology specialises in recombinant protein production, process and vaccine development from microbial expression systems. ARTES’ expression system Hansenula polymorpha is the preferred technology for affordable mass vaccination and recommended by the World Health Organization (WHO) for these purposes. In combination with ARTES’ METAVAX® platform, this offers a new, unique and economical approach to low-cost mass production of safe and effective vaccines required in the veterinary field.
US – Governor Terry E. Branstad travelled to Sioux Center last week to attend the grand opening for one of three Boehringer Ingelheim Vetmedica, Inc. (BIVI) specialised vaccine research facilities.
BARCELONA, SPAIN - An important anniversary in the history of porcine circovirus type 2 (PCV2) has been marked at a special international pig veterinary satellite symposium held in Barcelona, Spain in June 2011 as part of the 6th International Symposium on Emerging and Re-emerging Pig Diseases.
Ingelheim, Germany, 26 September 2018 – The winners of the 2018 European PRRS Research Award have been announced at this year’s international swine veterinary assembly by Boehringer Ingelheim Animal Health in Lisbon, Portugal.
Some highly positive messages about progress in the global fight against the Porcine Reproductive and Respiratory Syndrome have been delivered to the latest Asian PRRSspective Symposium, which was held in November 2017 in Fukuoka, Japan, with the support of the Japanese Association of Swine Veterinarians.
Oliver Duran
Get the latest news on Swine Health Subscribe to our newsletter